Eli Lilly Set to Close $2.4B Dice Therapeutics Acquisition to Treat Autoimmune Diseases

Coinspeaker Eli Lilly Set to Close $2.4B Dice Therapeutics Acquisition to Treat Autoimmune Diseases American pharmaceutical company Eli Lilly has announced it is set to purchase biopharma company Dice Therapeutics. Eli Lilly hopes the $2.4 billion deal will help the company develop more drugs to…#elilillyset #elililly #dicetherapeutics #dice #elilillyanddice #kevinjudice #elilillys #patrikjonsson #lilly #davidricks
Source: Reuters: Health - Category: Consumer Health News Source Type: news